Letter to the editor about "Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis"
- PMID: 36270446
- DOI: 10.1016/j.jad.2022.10.013
Letter to the editor about "Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis"
Conflict of interest statement
Conflict of interest The authors confirm that there have been no involvements that might raise the question of bias in the work reported or in the conclusions, implications, or opinions stated.
Comment in
-
Response to "Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.".J Affect Disord. 2023 Mar 1;324:68. doi: 10.1016/j.jad.2022.12.068. Epub 2022 Dec 24. J Affect Disord. 2023. PMID: 36574849 No abstract available.
Comment on
-
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.J Affect Disord. 2021 Jan 1;278:542-555. doi: 10.1016/j.jad.2020.09.071. Epub 2020 Sep 23. J Affect Disord. 2021. PMID: 33022440 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources